Detalhe da pesquisa
1.
Proteomics-based Model for Predicting the Risk of Brain Metastasis in Patients with Resected Lung Adenocarcinoma carrying the EGFR Mutation.
Int J Med Sci
; 21(4): 765-774, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464823
2.
Si, O-Codoped Carbonized Polymer Dots with High Chemiresistive Gas Sensing Performance at Room Temperature.
ACS Sens
; 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38864828
3.
High Tumor Mutation Burden and DNA Repair Gene Mutations are Associated with Primary Resistance to Crizotinib in ALK-Rearranged Lung Cancer.
Onco Targets Ther
; 14: 4809-4817, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34552337
4.
A study on different therapies and prognosis-related factors for brain metastases in lung adenocarcinoma patients with driver mutation.
Clin Exp Metastasis
; 37(3): 391-399, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32356218
5.
Induced pluripotent stem cell-derived enteric neural crest cells repopulate human aganglionic tissue-engineered intestine to form key components of the enteric nervous system.
J Tissue Eng
; 11: 2041731420905701, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32435442
6.
Predictive and prognostic value of phosphorylated c-KIT and PDGFRA in advanced non-small cell lung cancer harboring ALK fusion.
Oncol Lett
; 17(3): 3071-3076, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867736
7.
Erlotinib intercalating pemetrexed/cisplatin versus erlotinib alone in Chinese patients with brain metastases from lung adenocarcinoma: a prospective, non-randomised, concurrent controlled trial (NCT01578668).
ESMO Open
; 2(Suppl 1): e000112, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29147576
8.
CAS P8 -652 6N del polymorphism and breast cancer risk: a systematic review and meta-analysis.
Neth J Med
; 72(1): 10-6, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24457433